Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks

Cell Reports

Volumn 15, Issue 2, 2016, Pages 300-309

  Ribeyre, Cyril ^a   Zellweger, Ralph ^b   Chauvin, Maeva ^a   Bec, Nicole ^c   Larroque, Christian ^c   Lopes, Massimo ^b   Constantinou, Angelos ^a  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CAMPTOTHECIN; DNA TOPOISOMERASE; PROTEIN BAZ1B; PROTEIN SMARCA5; UNCLASSIFIED DRUG; BAZ1B PROTEIN, HUMAN; DNA; DNA TOPOISOMERASE INHIBITOR; NONHISTONE PROTEIN; SMARCA5 PROTEIN, HUMAN; TOP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA REPLICATION; DRUG CYTOTOXICITY; DRUG TOLERANCE; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; REPLICATION FORK; DRUG EFFECT; HELA CELL LINE; METABOLISM; PROCEDURES;

ADENOSINE TRIPHOSPHATASES; CAMPTOTHECIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA; DNA REPLICATION; DNA TOPOISOMERASES, TYPE I; HELA CELLS; HUMANS; MALE; PROTEOMICS; TOPOISOMERASE I INHIBITORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84962068600     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.03.027     Document Type: Article

References (44)

1. Adam S., Polo S.E., Almouzni G. Transcription recovery after DNA damage requires chromatin priming by the H3.3 histone chaperone HIRA. Cell 2013, 155:94-106.
2. Bermejo R., Doksani Y., Capra T., Katou Y.M., Tanaka H., Shirahige K., Foiani M. Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activation. Genes Dev. 2007, 21:1921-1936.
3. Culver-Cochran A.E., Chadwick B.P. Loss of WSTF results in spontaneous fluctuations of heterochromatin formation and resolution, combined with substantial changes to gene expression. BMC Genomics 2013, 14:740.
4. Durand-Dubief M., Persson J., Norman U., Hartsuiker E., Ekwall K. Topoisomerase I regulates open chromatin and controls gene expression in vivo. EMBO J. 2010, 29:2126-2134.
5. Dykhuizen E.C., Hargreaves D.C., Miller E.L., Cui K., Korshunov A., Kool M., Pfister S., Cho Y.J., Zhao K., Crabtree G.R. BAF complexes facilitate decatenation of DNA by topoisomerase IIα. Nature 2013, 497:624-627.
6. Francke U. Williams-Beuren syndrome: genes and mechanisms. Hum. Mol. Genet. 1999, 8:1947-1954.
7. Gavin I., Horn P.J., Peterson C.L. SWI/SNF chromatin remodeling requires changes in DNA topology. Mol. Cell 2001, 7:97-104.
8. Halmer L., Gruss C. Accessibility to topoisomerases I and II regulates the replication efficiency of simian virus 40 minichromosomes. Mol. Cell. Biol. 1997, 17:2624-2630.
9. Holm C., Covey J.M., Kerrigan D., Pommier Y. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res. 1989, 49:6365-6368.
10. Hsiang Y.H., Liu L.F., Wall M.E., Wani M.C., Nicholas A.W., Manikumar G., Kirschenbaum S., Silber R., Potmesil M. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Res. 1989, 49:4385-4389.
11. Husain A., Begum N.A., Taniguchi T., Taniguchi H., Kobayashi M., Honjo T. Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability. Nat. Commun. 2016, 7:10549.
12. Koster D.A., Palle K., Bot E.S., Bjornsti M.A., Dekker N.H. Antitumour drugs impede DNA uncoiling by topoisomerase I. Nature 2007, 448:213-217.
13. Lalli M.A., Jang J., Park J.C., Wang Y., Guzman E., Zhou H., Audouard M., Bridges D., Tovar K.R., Papuc S.M., et al. Haploinsufficiency of BAZ1B contributes to Williams syndrome through transcriptional dysregulation of neurodevelopmental pathways. Hum. Mol. Genet. 2016, ddw010.
14. Liu L.F., Wang J.C. Supercoiling of the DNA template during transcription. Proc. Natl. Acad. Sci. USA 1987, 84:7024-7027.
15. Lopez-Contreras A.J., Ruppen I., Nieto-Soler M., Murga M., Rodriguez-Acebes S., Remeseiro S., Rodrigo-Perez S., Rojas A.M., Mendez J., Muñoz J., Fernandez-Capetillo O. A proteomic characterization of factors enriched at nascent DNA molecules. Cell Rep. 2013, 3:1105-1116.
16. Lossaint G., Larroque M., Ribeyre C., Bec N., Larroque C., Décaillet C., Gari K., Constantinou A. FANCD2 binds MCM proteins and controls replisome function upon activation of s phase checkpoint signaling. Mol. Cell 2013, 51:678-690.
17. Madabhushi R., Gao F., Pfenning A.R., Pan L., Yamakawa S., Seo J., Rueda R., Phan T.X., Yamakawa H., Pao P.C., et al. Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes. Cell 2015, 161:1592-1605.
18. Meng L.H., Liao Z.Y., Pommier Y. Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy. Curr. Top. Med. Chem. 2003, 3:305-320.
19. Merrick C.J., Jackson D., Diffley J.F. Visualization of altered replication dynamics after DNA damage in human cells. J. Biol. Chem. 2004, 279:20067-20075.
20. Neelsen K.J., Chaudhuri A.R., Follonier C., Herrador R., Lopes M. Visualization and interpretation of eukaryotic DNA replication intermediates in vivo by electron microscopy. Methods Mol. Biol. 2014, 1094:177-208.
21. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 2006, 6:789-802.
22. Pommier Y. DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition. Chem. Rev. 2009, 109:2894-2902.
23. Pommier Y. Drugging topoisomerases: lessons and challenges. ACS Chem. Biol. 2013, 8:82-95.
24. Poot R.A., Bozhenok L., van den Berg D.L., Steffensen S., Ferreira F., Grimaldi M., Gilbert N., Ferreira J., Varga-Weisz P.D. The Williams syndrome transcription factor interacts with PCNA to target chromatin remodelling by ISWI to replication foci. Nat. Cell Biol. 2004, 6:1236-1244.
25. Poot R.A., Bozhenok L., van den Berg D.L., Hawkes N., Varga-Weisz P.D. Chromatin remodeling by WSTF-ISWI at the replication site: opening a window of opportunity for epigenetic inheritance?. Cell Cycle 2005, 4:543-546.
26. Postow L., Crisona N.J., Peter B.J., Hardy C.D., Cozzarelli N.R. Topological challenges to DNA replication: conformations at the fork. Proc. Natl. Acad. Sci. USA 2001, 98:8219-8226.
27. Pourquier P., Pommier Y. Topoisomerase I-mediated DNA damage. Adv. Cancer Res. 2001, 80:189-216.
28. Puc J., Kozbial P., Li W., Tan Y., Liu Z., Suter T., Ohgi K.A., Zhang J., Aggarwal A.K., Rosenfeld M.G. Ligand-dependent enhancer activation regulated by topoisomerase-I activity. Cell 2015, 160:367-380.
29. Ray Chaudhuri A., Hashimoto Y., Herrador R., Neelsen K.J., Fachinetti D., Bermejo R., Cocito A., Costanzo V., Lopes M. Topoisomerase I poisoning results in PARP-mediated replication fork reversal. Nat. Struct. Mol. Biol. 2012, 19:417-423.
30. Schwab R.A., Nieminuszczy J., Shah F., Langton J., Lopez Martinez D., Liang C.C., Cohn M.A., Gibbons R.J., Deans A.J., Niedzwiedz W. The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription. Mol. Cell 2015, 60:351-361.
31. Seiler J.A., Conti C., Syed A., Aladjem M.I., Pommier Y. The intra-S-phase checkpoint affects both DNA replication initiation and elongation: single-cell and -DNA fiber analyses. Mol. Cell. Biol. 2007, 27:5806-5818.
32. Sirbu B.M., Couch F.B., Feigerle J.T., Bhaskara S., Hiebert S.W., Cortez D. Analysis of protein dynamics at active, stalled, and collapsed replication forks. Genes Dev. 2011, 25:1320-1327.
33. Sirbu B.M., McDonald W.H., Dungrawala H., Badu-Nkansah A., Kavanaugh G.M., Chen Y., Tabb D.L., Cortez D. Identification of proteins at active, stalled, and collapsed replication forks using isolation of proteins on nascent DNA (iPOND) coupled with mass spectrometry. J. Biol. Chem. 2013, 288:31458-31467.
34. Sollier J., Stork C.T., García-Rubio M.L., Paulsen R.D., Aguilera A., Cimprich K.A. Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability. Mol. Cell 2014, 56:777-785.
35. Sordet O., Liao Z., Liu H., Antony S., Stevens E.V., Kohlhagen G., Fu H., Pommier Y. Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis. J. Biol. Chem. 2004, 279:33968-33975.
36. Sordet O., Redon C.E., Guirouilh-Barbat J., Smith S., Solier S., Douarre C., Conti C., Nakamura A.J., Das B.B., Nicolas E., et al. Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep. 2009, 10:887-893.
37. Sperling A.S., Jeong K.S., Kitada T., Grunstein M. Topoisomerase II binds nucleosome-free DNA and acts redundantly with topoisomerase I to enhance recruitment of RNA Pol II in budding yeast. Proc. Natl. Acad. Sci. USA 2011, 108:12693-12698.
38. Strumberg D., Pilon A.A., Smith M., Hickey R., Malkas L., Pommier Y. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff. Mol. Cell. Biol. 2000, 20:3977-3987.
39. Teves S.S., Henikoff S. Transcription-generated torsional stress destabilizes nucleosomes. Nat. Struct. Mol. Biol. 2014, 21:88-94.
40. Tuduri S., Crabbé L., Conti C., Tourrière H., Holtgreve-Grez H., Jauch A., Pantesco V., De Vos J., Thomas A., Theillet C., et al. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nat. Cell Biol. 2009, 11:1315-1324.
41. Wang J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 2002, 3:430-440.
42. Xiao A., Li H., Shechter D., Ahn S.H., Fabrizio L.A., Erdjument-Bromage H., Ishibe-Murakami S., Wang B., Tempst P., Hofmann K., et al. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature 2009, 457:57-62.
43. Zellweger R., Dalcher D., Mutreja K., Berti M., Schmid J.A., Herrador R., Vindigni A., Lopes M. Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells. J. Cell Biol. 2015, 208:563-579.
44. Zeman M.K., Cimprich K.A. Causes and consequences of replication stress. Nat. Cell Biol. 2014, 16:2-9.